According to Marksans Pharma 's latest financial reports the company's current revenue (TTM) is $0.25 B. In 2022 the company made a revenue of $0.22 B an increase over the years 2021 revenue that were of $0.18 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.25 B | 14.39% |
2022 | $0.22 B | 18.09% |
2021 | $0.18 B | 1.81% |
2020 | $0.18 B | 26.57% |
2019 | $0.14 B | 7.15% |
2018 | $0.13 B | -1.79% |
2017 | $0.13 B | 17.56% |
2016 | $0.11 B | -10.38% |
2015 | $0.13 B | 3.21% |
2014 | $0.12 B | 28.31% |
2013 | $99.48 M |